Biogen scales back Apellis programs, trims research roles after $5.6 billion buyout

Biogen scales back Apellis programs, trims research roles after $5.6 billion buyout | Reuters — Reuters

Biogen scales back Apellis programs, trims research roles after $5.6 billion buyout | Reuters